Skip to Content
Merck
  • Pharmacokinetic profile of conjugated verrucarol urinary metabolites in dogs.

Pharmacokinetic profile of conjugated verrucarol urinary metabolites in dogs.

Biopharmaceutics & drug disposition (1994-10-01)
S Barel, B Yagen, M Bialer
ABSTRACT

The pharmacokinetics and renal excretion of a trichothecene mycotoxin, verrucarol, were studied in six mongrel dogs following IV administration (0.4 mg kg-1). The fraction of verrucarol excreted intact in the urine ranged from 0.9% to 2.7% of the administered dose. The fraction of verrucarol metabolites excreted in the urine was 32-60% for verrucaryl glucuronides and 32-47% for verrucaryl sulphates. These urinary conjugated metabolites were analysed quantitatively following their enzymatic hydrolysis. The half-life of verrucarol calculated from the urinary data of its conjugated metabolites was not significantly different from the half-life calculated from the plasma data of the parent compound.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Verrucarol